All data are based on the daily closing price as of May 16, 2025
n
Nippon Shinyaku
4516.TSE
23.37 USD
0.66
+2.91%
Overview
Last close
23.37 usd
Market cap
1.57B usd
52 week high
35.27 usd
52 week low
17.41 usd
Target price
28.71 usd
Valuation
P/E
7.0274
Forward P/E
12.9199
Price/Sales
1.428
Price/Book Value
0.9263
Enterprise Value
1.19B usd
EV/Revenue
1.08
EV/EBITDA
4.0916
Key financials
Revenue TTM
1.10B usd
Gross Profit TTM
749.27M usd
EBITDA TTM
284.74M usd
Earnings per Share
3.32 usd
Dividend
N/A usd
Total assets
1.82B usd
Net debt
-338.88M usd
About
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.